Evidence map›Paper›PMID 40220022›Full record

SynthesisJournal of robotic surgery2025

Evaluating the safety, feasibility, and outcomes of the Senhance robotic system in robot-assisted radical prostatectomy: a systematic review and single-arm meta-analysis.

Jian-Wei Yang, Li Wang, Yalong Zhang, Shun Wan, Kun-Peng Li, Kang-Yu Wang, Xiao-Ran Li, Si-Yu Chen, Li Yang

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jian-Wei Yang *Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Li Wang *Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Yalong Zhang *Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Shun WanDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Kun-Peng LiDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Kang-Yu WangDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Xiao-Ran LiDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China.
Si-Yu ChenDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China. 1432996042@qq.com.
Li YangDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, People's Republic of China. ery_yangli@lzu.edu.cn.

Funding

Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital No. CY2023-BJ-04Cuiying Student Research Program of Lanzhou University Second Hospital No.CYXZ2024-20Natural Science Foundation of Gansu Province No. 25JRRA584
6 · The paper itself

Abstract

With the continuous advancement of robotic-assisted surgical platforms, evaluating the safety and feasibility of emerging systems is essential. This study aims to systematically assess the Senhance robotic system in performing radical prostatectomy for prostate cancer. This investigation employed a systematic review paired with a single-arm meta-analysis, conducted in line with PRISMA standards and with the study protocol pre-registered in the PROSPERO database (CRD42025636976). We queried major databases-including PubMed, Web of Science, Embase, and the Cochrane Library-for articles published until December 2024 that focused on the utilization of the Senhance robotic system in radical prostatectomy. Relevant data were extracted on key surgical parameters (e.g., duration of the procedure, intraoperative blood loss, length of hospital stay, and catheter removal time), as well as on postoperative pain levels and oncological outcomes (including positive surgical margin rates, biochemical recurrence, and urinary incontinence), in addition to overall complication rates. All analyses were performed using Stata 18 SE; heterogeneity among studies was quantified using the I

Indexed as

ProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresBlood Loss, SurgicalFeasibility StudiesHumansLength of StayMaleOperative TimePostoperative ComplicationsPostoperative PainTreatment OutcomeMeta-analysisMinimally invasive surgeryProstate cancerRadical prostatectomyRobot-assisted surgerySenhance robotic system

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.